Key statistics
On Thursday, United Therapeutics Corp (UTHR:NSQ) closed at 367.42, -12.06% below its 52-week high of 417.82, set on Nov 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 367.20 |
---|---|
High | 370.34 |
Low | 361.58 |
Bid | 366.00 |
Offer | 375.00 |
Previous close | 364.33 |
Average volume | 355.42k |
---|---|
Shares outstanding | 44.64m |
Free float | 43.82m |
P/E (TTM) | 16.15 |
Market cap | 16.40bn USD |
EPS (TTM) | 22.75 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
More ▼